Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Issue : The Pharmaceutical Journal, 31 January 2015, Vol 294, No 7847

Sort by: Newest first Oldest first A-Z Z-A

  • Erythroped Forte, glycopyrronium, Hytrin and methotrexate out of stock Subscription

    22 JAN 2015 14:29

    The following products are currently out of stock from Amdipharm Mercury: Erythroped Forte SF (erythromycin ethyl succinate) suspension 500mg/5ml, 140ml x 20, glycopyrronium bromide solution for injection 200µg/ml x 10 ampoules; glycopyrronium bromide solution for injection 600µg/3ml x 3 ampoules; and glycopyrronium 0.5mg/ml and neostigmine 2.5mg/ml injection; hytrin tablets 2mg and 5mg, both x 28; and methotrexate tablets 2.5mg x 24. All products are due back in stock by February 2015 ...

  • Chloroquine sulphate syrup has been discontinued Subscription

    22 JAN 2015 14:27

    Chloroquine sulphate syrup (Nivaquine; Sanofi) has been discontinued and will no longer be marketed in the UK. The expiry date for the last batch supplied is March 2015. Other chloroquine phosphate syrup preparations are not currently available in the UK. As an alternative, chloroquine phosphate is available in a tablet form used alone or in combination with proguanil. 

  • Women taking valproate should be told about risks of developmental disorders in offspring Subscription

    21 JAN 2015 17:50

    Women taking valproate should be told about the risks of developmental disorders in children exposed to the drug during pregnancy, says the UK medicines regulator.

  • The cost of vaccines recommended by the World Health Organization (WHO) for developing countries has increased by 68%, warns Médecins sans Frontières (MSF)

    Cost of vaccines becoming unaffordable in developing countries, charity warns Subscription

    21 JAN 2015 12:34 By Debbie Andalo

    The cost of vaccines recommended by the World Health Organization has gone up 68-fold over the past 13 years, according to international aid charity Médecins sans Frontières.

  • Audit highlights problem of patients taking NSAIDs without gastroprotection Subscription

    21 JAN 2015 9:54

    Many patients taking non-steroidal anti-inflammatory drugs are not co-prescribed gastroprotective agents, an audit of community pharmacies in England has found.

  • The Cancer Drugs Fund has undermined the National Institute for Health and Care Excellence and has provided a “get out of jail card” for pharmaceutical companies.

    Cancer Drugs Fund has undermined NICE, its chair admits Subscription

    20 JAN 2015 17:10 By Janna Lawrence

    The Cancer Drugs Fund has undermined the National Institute for Health and Care Excellence and has provided a “get out of jail card” for pharmaceutical companies, its chair says.

  • Light micrograph of liver sarcoidosis, a non-malignant immunological disorder characterised by non-caseating (non-necrotising) granulomas.

    Identifying and managing sarcoidosis Subscription

    20 JAN 2015 By Lloyd Mayers, Sarah Mulholland

    Sarcoidosis is a complex immunological disorder that requires careful management and vigilant monitoring.

  • David Taylor, pharmacist, academic and one of the top clinical leaders in Britain in 2014

    Answering clinical conundrums as a psychiatry research leader Subscription

    19 JAN 2015 16:35 By Stephen Robinson

    Pharmacist and academic David Taylor, lead author of ‘The Maudsley prescribing guidelines’, was named as one of the top clinical leaders in Britain in 2014. He discusses why he believes pharmacy’s future lies in clinical aspects of care and research.

  • Cost of cancer drugs Subscription

    19 JAN 2015 16:06

    Elizabeth Sukkar, deputy news editor of The Pharmaceutical Journal, talked to BBC Radio Leicester about the cost of cancer drugs and cost of developing new medicines.

  • Assisted dying laws Subscription

    19 JAN 2015 13:04

    14 January 2015: The Times and The Scotsman reported that Holyrood was considering new laws to allow assisted dying in Scotland. They focused on the fact that “doctors in Scotland have demanded a ‘conscience clause’ be inserted into new laws on assisted suicide”.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.